Clinical Trial Update: Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia [NA]

View source ↗

Summary

An investigation using deep rTMS to modulate insula synaptic density and smoking behavior in individuals with schizophrenia has been terminated (NCT05724810).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Tobacco Use Disorder

Snippet

Sponsor: Stony Brook University | Conditions: Schizophrenia, Smoking Cessation | NA | Status: TERMINATED